000 01649 a2200493 4500
005 20250516191032.0
264 0 _c20150615
008 201506s 0 0 eng d
022 _a1573-2576
024 7 _a10.1007/s10753-013-9802-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Pin
245 0 0 _aIL-33 neutralization suppresses lupus disease in lupus-prone mice.
_h[electronic resource]
260 _bInflammation
_cJun 2014
300 _a824-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies
_xblood
650 0 4 _aAntibodies, Antinuclear
_xblood
650 0 4 _aAntigen-Antibody Complex
_xblood
650 0 4 _aComplement C3
_ximmunology
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmune Complex Diseases
_xdrug therapy
650 0 4 _aImmunoglobulin G
_ximmunology
650 0 4 _aInflammation
_ximmunology
650 0 4 _aInterleukin-17
_xblood
650 0 4 _aInterleukin-1beta
_xblood
650 0 4 _aInterleukin-33
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aInterleukins
_xantagonists & inhibitors
650 0 4 _aKidney
_xinjuries
650 0 4 _aLupus Erythematosus, Systemic
_ximmunology
650 0 4 _aLupus Nephritis
_xdrug therapy
650 0 4 _aMice
650 0 4 _aMyeloid Cells
_ximmunology
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
650 0 4 _aTh17 Cells
_ximmunology
700 1 _aLin, Wei
700 1 _aZheng, Xiangxiong
773 0 _tInflammation
_gvol. 37
_gno. 3
_gp. 824-32
856 4 0 _uhttps://doi.org/10.1007/s10753-013-9802-0
_zAvailable from publisher's website
999 _c23424965
_d23424965